Subject: Fw: KSA Tickets violation
From: Saurabh Dadu <[email-masked]>
To: Apoorv Joshi <[email-masked]>
Date: Mon, 1 Aug 2022 08:54:51 +0000

Saurabh Dadu
LiveSalesman
India: +91 120 4332621 x 17
US: 1 240 949 2437
Cell: +91 9810175203
________________________________
From: Mahmoud Emadeldin Mahmoud Elsayed <[email-masked]>
Sent: 27 July 2022 4:05 PM
To: Saurabh Dadu <[email-masked]>; Deeksha Dadu <[email-masked]>
Cc: mustehsan.siddiqui <[email-masked]>; Malik Ismail <[email-masked]>; Mohd Imran <[email-masked]>
Subject: RE: KSA Tickets violation

Hi Saurabh,

Please find attached as requested.

From: Saurabh Dadu <[email-masked]>
Sent: Wednesday, July 27, 2022 2:11 PM
To: Mahmoud Emadeldin Mahmoud Elsayed <[email-masked]>; Deeksha Dadu <[email-masked]>
Cc: Mustehsan Siddiqui <[email-masked]>; Malik Ismail <[email-masked]>; Mohd Imran <[email-masked]>
Subject: Re: KSA Tickets violation

CAUTION: External email sender. Use care when clicking on links or opening attachments!

Dear Mahmoud,

Can you please also share the raw data for this?

Saurabh Dadu

LiveSalesman

India: +91 120 4332621 x 17

US: 1 240 949 2437

Cell: +91 9810175203

________________________________

From: Mahmoud Emadeldin Mahmoud Elsayed <[email-masked]<mailto:[email-masked]>>
Sent: 27 July 2022 3:30 PM
To: Saurabh Dadu <[email-masked]<mailto:[email-masked]>>; Deeksha Dadu <[email-masked]<mailto:[email-masked]>>
Cc: mustehsan.siddiqui <[email-masked]<mailto:[email-masked]>>; Malik Ismail <[email-masked]<mailto:[email-masked]>>; Mohd Imran <[email-masked]<mailto:[email-masked]>>
Subject: KSA Tickets violation

Hi All,

Please find below is total response from LSM team on KSA tickets, which still assigned to KSA team.

That can’t be mistakenly responses from LSM teams as it 29.8% for “July2022” from total response in KSA group.

Agent

Responses

Apoorv Joshi

31

Aya Saoud

57

Badri .

12

Elharith elsiddig

109

LSM Automation Bot

2054

Mais Said

5

Maya Shamma

483

Mohammad Tawfik

390

Mohammed Murshed

20

Mohammed yahya

92

Sohaib Ahmed

83

Ziena Saeed

271

This e-mail message (which includes attachment/s thereto, if any, and the information therein), is legally privileged, proprietary, strictly confidential and exempt from disclosure, which is not waived or lost by mis-transmission or error. If you are not the original intended recipient of this message, it may be unlawful and illegal for you to read, print, retain, copy, disseminate, disclose or otherwise use this message, or take any action in reliance on it, and the same is prohibited and forbidden. If you have received this email in error, please notify the sender immediately by return reply and delete the message from your system without printing or making a copy. Neither the sender nor we are liable for any loss or damage as a result of this message, or for any delay, interception, corruption, virus, error, omission, improper or incomplete transmission thereof. www.landmarkgroup.com<http://www.landmarkgroup.com>

This e-mail message (which includes attachment/s thereto, if any, and the information therein), is legally privileged, proprietary, strictly confidential and exempt from disclosure, which is not waived or lost by mis-transmission or error. If you are not the original intended recipient of this message, it may be unlawful and illegal for you to read, print, retain, copy, disseminate, disclose or otherwise use this message, or take any action in reliance on it, and the same is prohibited and forbidden. If you have received this email in error, please notify the sender immediately by return reply and delete the message from your system without printing or making a copy. Neither the sender nor we are liable for any loss or damage as a result of this message, or for any delay, interception, corruption, virus, error, omission, improper or incomplete transmission thereof. www.landmarkgroup.com